IP Library Granted Patent US 9,545,737
Granted Patent B2
US 9,545,737 · App. 13/950,447 · Granted Jan 17, 2017

System and method for producing particles and patterned films

Inventors: Robert Henn (Raleigh, NC); Alex Ermoshkin (Chapel Hill, NC); Kyle Henn (Raleigh, NC); Benjamin Maynor (Durham, NC); Jason Rolland (Belmont, MA); Robert Praino (Westwood, MA)
Assignee: LIQUIDIA TECHNOLOGIES, INC.
B29C43/00B29C33/42B29L2031/7562Y10T428/2982
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,545,737
App. No.
13/950,447
Granted
Jan 17, 2017
Kind
B2
Abstract

A system including a mold having a fluoropolymer wherein the mold defines a plurality of cavities having a predetermined shape and a cross-sectional dimension less than about 100 micrometers; a roller; a surface in cooperation with the roller to form a nip point configured to receive the mold, wherein the nip point is further configured to receive a substantially liquid composition and accelerate entry of the substantially liquid composition into the cavity. A method of forming particles including applying a substantially liquid composition to a mold, wherein the mold comprises a fluoropolymer and defines a plurality of cavities each having a broadest cross-sectional dimension of less than about 100 micrometers; nipping the mold between a roller and a surface such that the substantially liquid composition enters the cavities of the mold; and hardening the substantially liquid composition in the cavities of the mold to form a particle within each cavity, wherein the particle has a size and shape that substantially mimics the size and shape of the cavity of the mold.

Claims (29)

1. A method of forming pharmaceutical particles, comprising:

applying a composition between a mold and a sheet, wherein the mold defines a plurality of micro or nano cavities each having a broadest cross-sectional dimension of less than about 100 micrometers;

passing the mold, the composition and the sheet through a heated nip point such that the composition between the mold and the sheet is heated by the heated nip point and enters the micro or nano cavities of the mold;

allowing the composition in the micro or nano cavities of the mold to cool and form the pharmaceutical particles in the micro or nano cavities of the mold; and

separating the mold and the sheet to remove the pharmaceutical particles from the micro or nano cavities of the mold and provide a plurality of independent pharmaceutical particles.

2. The method of claim 1 , further comprising sterilizing the pharmaceutical particles.

3. The method of claim 1 , further comprising purifying the pharmaceutical particles.

4. The method of claim 1 , further comprising treating the pharmaceutical particles to couple a drug, biologic, antigen or adjuvant to a surface of the pharmaceutical particles.

5. The method of claim 1 , wherein the composition is applied in an amount substantially equal to the volume of the micro or nano cavities of the mold.

6. The method of claim 1 , wherein the heated nip point comprises an adjustable nip point configured to move to apply pressure to the mold, the composition and the sheet as the mold, the composition, and the sheet are passed through the heated nip point.

7. The method of claim 6 , further comprising, while passing the mold, composition and the sheet through the heated nip point, applying pressure through the heated nip point to urge the composition into the micro or nano cavities of the mold.

8. The method of claim 1 , wherein the heated nip point comprises a roller that is not driven.

9. The method of claim 8 , wherein the roller is heated.

10. The method of claim 1 , wherein the heated nip point comprises a driven heated roller.

11. The method of claim 1 , wherein the composition comprises a biocompatible polymer.

12. The method of claim 1 , wherein the composition comprises at least one of a therapeutic agent, a diagnostic agent, a pharmaceutical agent, a drug, genetic material, a nucleotide sequence, an amino-acid sequence, a ligand, an oligopeptide, a protein, a vaccine, a biologic, DNA, or RNA.

13. The method of claim 1 , further comprising harvesting the pharmaceutical particles from the sheet after the pharmaceutical particles are removed from the micro or nano cavities of the mold.

14. A method of forming micro or nano-particles, comprising:

applying a composition between a mold and a sheet, wherein the mold defines a plurality of micro or nano cavities each having a broadest cross-sectional dimension of less than about 100 micrometers;

passing the mold, the composition and the sheet through a heated adjustable nip point;

adjusting the heated adjustable nip point to apply pressure to the mold, the composition and the sheet as the mold, the composition and the sheet pass through the heated adjustable nip point;

heating the mold, the composition and the sheet in the heated adjustable nip point to flow the composition into the micro or nano cavities of the mold as the mold, composition and the sheet pass through the heated adjustable nip point; and

allowing the composition in the micro or nano cavities of the mold to cool and form particles in the micro or nano cavities of the mold; and

separating the mold and the sheet to remove the particles from the micro or nano cavities of the mold and provide a plurality of independent particles.

15. The method of claim 14 , further comprising harvesting the particles from the sheet after the particles are removed from the micro or nano cavities of the mold.

16. The method of claim 14 , further comprising sterilizing or purifying the particles.

17. The method of claim 14 , further comprising applying an amount of the composition substantially equal to the volume of the micro or nano cavities of the mold.

18. The method of claim 14 , wherein the heated adjustable nip point comprises a roller that is not driven.

19. The method of claim 14 , wherein the heated adjustable nip point comprises a driven roller.

Assignments (3)
ASSIGNMENT OF IP SECURITY AGREEMENT RECORDED AT REEL/FRAME 062643/0791 Recorded May 11, 2023
From: HCR COLLATERAL MANAGEMENT, LLC, AS RETIRING SUBORDINATED LENDER
To: HEALTHCARE ROYALTY PARTNERS IV, L.P., AS SUCCESSOR SUBORDINATED LENDER
Reel/Frame 063627/0307 →
SECURITY INTEREST Recorded Feb 9, 2023
From: LIQUIDIA TECHNOLOGIES, INC.
To: HCR COLLATERAL MANAGEMENT, LLC
Reel/Frame 062643/0791 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 13, 2013
From: HENN, ROBERT; ERMOSHKIN, ALEX; HENN, KYLE; MAYNOR, BENJAMIN; ROLLAND, JASON; PRAINO, ROBERT
To: LIQUIDIA TECHNOLOGIES, INC.
Reel/Frame 031396/0087 →
Continuity (4)
Continuation 13156147 · Jun 8, 2011
Continuation 12250461 · Oct 13, 2008
Provisional Application 60979710 · Oct 12, 2007
Related Publication 20140027948A1 · Jan 30, 2014